Median IGFBP7 at baseline was higher in the group who developed liver fibrosis according to ELF ≥ 9.8 at follow‐up compared to the group with ELF remaining < 9.8 at follow‐up (220.0 [IQR: 207.6–243.6] vs. 192.8 [IQR: 173.3–207.9] [p = 0.001]) (Figure 4A, Table S3). This evidence concerns the gene IGFBP7 and Hepatic fibrosis.